Caenorhabditis elegans as a model for lysosomal storage disorders

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 7-8, 2008, Pages 433-446

  de Voer, Gert ^a   Peters, Dorien ^a   Taschner, Peter E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Caenorhabditis elegans; Lysosomal storage disease; Lysosome

Indexed keywords

CATHEPSIN; CELL PROTEIN; CHLORIDE CHANNEL; GLYCOPROTEIN; CAENORHABDITIS ELEGANS PROTEIN; CHOLESTEROL; CUP 5 PROTEIN, C ELEGANS; CUP-5 PROTEIN, C ELEGANS; MCOLN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL M;

AMINO ACID SEQUENCE; BIOGENESIS; CAENORHABDITIS ELEGANS; CELL FUNCTION; CHOLESTEROL TRANSPORT; DANON DISEASE; DEVELOPMENTAL STAGE; ENDOCYTOSIS; GENE; GENE IDENTIFICATION; GENE MUTATION; HUMAN; LIPOFUSCINOSIS; LYSOSOME; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2 GENE; LYSOSOME STORAGE DISEASE; MCOLN1 GENE; MUCOLIPIDOSIS TYPE IV; MUTANT; NCP1 GENE; NCP2 GENE; NEURONAL CEROID LIPOFUSCINOSES; NIEMANN PICK DISEASE; NONHUMAN; OCULAR ALBINISM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; ANIMAL; ANIMAL MODEL; GENE TARGETING; GENETICS; METABOLISM; MUCOLIPIDOSIS; MUTATION; SPECIES DIFFERENCE;

ANIMALIA; CAENORHABDITIS ELEGANS;

ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CHOLESTEROL; GENE TARGETING; GENES, HELMINTH; HERMANSKI-PUDLAK SYNDROME; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; MEMBRANE PROTEINS; MODELS, ANIMAL; MUCOLIPIDOSES; MUTATION; NIEMANN-PICK DISEASE, TYPE C; PHENOTYPE; SPECIES SPECIFICITY; TRPM CATION CHANNELS;

EID: 49649113915     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.04.003     Document Type: Review

References (93)

1. De Duve C. The lysosome. Sci. Am. 208 (1963) 64-72
2. Eskelinen E.L., Tanaka Y., and Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 3 (2003) 137-145
3. Sun-Wada G.H., Wada Y., and Futai M. Lysosome and lysosome-related organelles responsible for specialized functions in higher organisms, with special emphasis on vacuolar-type proton ATPase. Cell Struct. Funct. 28 (2003) 455-463
4. Mullins C., and Bonifacino J.S. The molecular machinery for lysosome biogenesis. BioEssays 4 (2001) 333-343
5. Luzio J.P., Poupon V., Lindsay M.R., Mullock B.M., Piper R.C., and Pryor P.R. Membrane dynamics and the biogenesis of lysosomes. Mol. Membr. Biol. 2 (2003) 141-154
6. Grant B.D., and Sato M. Intracellular trafficking. In: WormBook (Ed). The C. elegans Research Community (January 21, 2006). http://www.wormbook.org 10.1895/wormbook.1.77.1 http://www.wormbook.org
7. Guerardel Y., Balanzino L., Maes E., Leroy Y., Coddeville B., Oriol R., and Strecker G. The nematode Caenorhabditis elegans synthesizes unusual O-linked glycans: identification of glucose-substituted mucin-type O-glycans and short chondroitin-like oligosaccharides. Biochem. J. 357 (2001) 167-182
8. K. Paschinger, M. Gutternigg, D. Rendic, I.B.H. Wilson, The N-glycosylation pattern of Caenorhabditis elegans. Carbohydr. Res. (electronic publication ahead of print).
9. Lochnit G., Bongaards R., and Geyer R. Searching new targets for anthelminthic strategies: interference with glycosphingolipid biosynthesis and phosphorylcholine metabolism affects development of Caenorhabditis elegans. Int. J. Parasitol. 35 (2005) 911-923
10. In: Scriver C.R., and Sly W.S. (Eds). The metabolic and molecular basis of inherited disease. 8th edition (2000), McGraw-Hill, Inc., New York
11. Pompe J.C. Over idiopathische hypertrophie van het hart Dutch. Ned. Tijdschr. Geneeskd. 76 (1932) 304-312
12. Hirschhorn R., and Reuser A.J.J. Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In: Scriver C.R., and Sly W.S. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 8th edition (2001), McGraw-Hill Inc., New York 3389-3420
13. Kornfeld S., and Sly W.S. I-cell disease and pseudo-Hurler polydystrophy: disorders of lysosomal enzyme phosphorylation and localization. In: Scriver C.R., and Sly W.S. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 8th edition (2001), McGraw-Hill Inc., New York 3421-3452
14. Vellodi A. Lysosomal storage disorders. Br. J. Haematol. 128 (2005) 413-431
15. Rapola J. Neuronal ceroid-lipofuscinoses in childhood. Perspect. Pediatr. Pathol. 17 (1993) 7-44
16. Schiffmann R., and Brady R.O. New prospects for the treatment of lysosomal storage diseases. Drugs 62 (2002) 733-742
17. Futerman A.H., and van Meer G. The cell biology of lysosomal storage disorders. Nat. Rev., Mol. Cell Biol. 7 (2004) 554-565
18. Brenner S. The genetics of Caenorhabditis elegans. Genetics 77 (1974) 71-94
19. Kuwabara P.E., and O'Neil N. The use of functional genomics in C. elegans for studying human development and disease. J. Inherit. Metab. Dis. 24 (2001) 127-138
20. Clokey G.V., and Jacobson L.A. The autofluorescent "lipofuscin granules" in the intestinal cells of Caenorhabditis elegans are secondary lysosomes. Mech. Ageing Dev. 35 (1986) 79-94
21. Treusch S., Knuth S., Slaugenhaupt S.A., Goldin E., Grant B.D., and Fares H. Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4483-4488
22. Kostich M., Fire A., and Fambrough D.M. Identification and molecular-genetic characterization of a LAMP/CD68-like protein from Caenorhabditis elegans. J. Cell Sci. 113 (2000) 2595-2606
23. Fares H., and Greenwald I. Genetic analysis of endocytosis in Caenorhabditis elegans: coelomocyte uptake defective mutants. Genetics 159 (2001) 133-145
24. Hermann G.J., Schroeder L.K., Hieb C.A., Kershner A.M., Rabbitts B.M., Fonarev P., Grant B.D., and Priess J.R. Genetic analysis of lysosomal trafficking in Caenorhabditis elegans. Mol. Biol. Cell 16 (2005) 3273-3288
25. WormBase web site, http://www.wormbase.org, release WS173, date March 23, 2007.
26. Kim S.L., Lund J., Kiraly M., Duke K., Jiang M., Stuart J.M., Eizinger A., Wylie B.N., and Davidson G.S. A gene expression map for Caenorhabditis elegans. Science 293 (2001) 2087-2092
27. Kamath R.S., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M., Kanapin A., Le Bot N., Moreno S., Sohrmann M., Welchman D.P., Zipperlen P., and Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421 (2003) 231-237
28. Bargal R., Avidan N., Ben-Asher E., Olender Z., Zeigler M., Frumkin A., Raas-Rothschild A., Glusman G., Lancet D., and Bach G. Identification of the gene causing Mucolipidosis type IV. Nat. Genet. 26 (2000) 118-123
29. Bassi M.T., Manzoni M., Monti E., Pizzo M.T., Ballabio A., and Borsani G. Cloning of the gene encoding a novel integral membrane protein, mucolipidin- and identification of the two major founder mutations causing Mucolipidosis type IV. Am. J. Hum. Genet. 67 (2000) 1110-1120
30. Sun M., Goldin E., Stahl S., Falardeau J.L., Kennedy J.C., Acierno Jr. J.S., Bove C., Kaneski C.R., Nagle J., Bromley M.C., Colman M., Schiffmann R., and Slaugenhaupt S.A. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum. Mol. Genet. 9 (2000) 2471-2478
31. Raychowdhury M.K., Gonzalez-Perrett S., Montalbetti N., Timpanaro G.A., Chasan B., Goldmann W.H., Stahl S., Cooney A., Goldin E., and Cantiello H.F. Molecular pathophysiology of Mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel. Hum. Mol. Genet. 13 (2004) 617-627
32. Hersh B.M., Hartwieg E., and Horvitz H.R. The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4355-4360
33. Fares H., and Greenwald I. Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. Nat. Genet. 28 (2001) 64-68
34. Schaheen L., Dang H., and Fares H. Basis of lethality in C. elegans lacking CUP-5, the Mucolipidosis type IV orthologue. Dev. Biol. 293 (2006) 382-391
35. LaPlante J.M., Falardeau J., Sun M., Kanazirska M., Brown E.M., Slaugenhaupt S.A., and Vassilev P.M. Identification and characterization of the single channel function of human mucolipin-1 implicated in Mucolipidosis type IV, a disorder affecting the lysosomal pathway. FEBS Lett. 532 (2002) 183-187
36. Pryor P.R., Mullock B.M., Bright N.A., Gray S.R., and Luzio J.P. The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. (2000) 1053-1062
37. Schaheen L., Patton G., and Fares H. Suppression of the cup-5 Mucolipidosis type IV-related lysosomal dysfunction by the inactivation of an ABC transporter in C. elegans. Development 133 (2006) 3939-3948
38. Vanier M.T., and Suzuki K. Niemann-Pick disease. In: Moser H.W. (Ed). Neurodystrophies and Neurolipidioses. Handbook of Clinical Neurology vol. 66 (1996), Elsevier B.V., Amsterdam 133-162
39. Schuchman E.H., and Desnick R.J. Type A and B Niemann-Pick disease: deficiencies of acid sphingomyelinase activity. In: Scriver C.R., and Sly W.S. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 8th edition (2001), McGraw-Hill Inc., New York 3589-3610
40. Carstea E.D., Morris J.A., Coleman K.G., Loftus S.K., Zhang D., Cummings C., Gu J., Rosenfeld M.A., Pavan W.J., Krizman D.B., Nagle J., Polymeropoulos M.H., Sturley S.L., Ioannou Y.A., Higgins M.E., Comly M., Cooney A., Brown A., Kaneski C.R., Blanchette-Mackie E.J., Dwyer N.K., Neufeld E.B., Chang T.Y., Liscum L., Strauss III J.F., Ohno K., Zeigler M., Carmi R., Sokol J., Markie D., O'Neill R.R., van Diggelen O.P., Elleder M., Patterson M.C., Brady R.O., Vanier M.T., Pentchev P.G., and Tagle D.A. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277 (1997) 228-231
41. Lin X., Hengartner M.O., and Kolesnick R. Caenorhabditis elegans contains two distinct acid sphingomyelinases. J. Biol. Chem. 273 (1998) 14374-14379
42. Naureckiene S., Sleat D.E., Lackland H., Fensom A., Vanier M.T., Wattiaux R., Jadot M., and Lobel P. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 290 (2000) 2298-2301
43. Neufeld E.N., Wastney M., Patel S., Suresh S., Cooney A.M., Dwyer N.K., Roff C.F., Ohno K., Morris J.A., Carstea E.D., Incardona J.P., Strauss III J.F., Vanier M.T., Patterson M.C., Brady R.O., Pentchev P.G., and Blanchette-Mackie E.J. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J. Biol. Chem. 274 (1999) 9627-9635
44. Sym M., Basson M., and Johnson C. A model for Niemann-Pick type C disease in the nematode Caenorhabditis elegans. Curr. Biol. 10 (2000) 527-530
45. Li J., Brown G., Ailion M., Lee S., and Thomas J.H. NCR-1 and NCR-2, the C. elegans homologs of the human Niemann-Pick type C1 disease protein, function upstream of DAF-9 in the dauer formation pathways. Development 131 (2004) 5741-5752
46. Gerisch B., and Antebi A. Hormonal signals produced by DAF-9/cytochrome P450 regulate C. elegans dauer diapause in response to environmental cues. Development 131 (2004) 1765-1776
47. Mak H.Y., and Ruvkun G. Intercellular signaling of reproductive development by the C. elegans DAF-9 cytochrome P450. Development 131 (2004) 1777-1786
48. Nishino I., Fu J., Tanji K., Yamada T., Shimojo S., Koori T., Mora M., Riggs J.E., Oh S.J., Koga Y., Sue C.M., Yamamoto A., Murakami N., Shanske S., Byrne E., Bonilla E., Nonaka I., DiMauro S., and Hirano M. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406 (2000) 906-910
49. Danon M.J., Oh S.J., DiMauro S., Manaligod J.R., Eastwood A., Naidu S., and Schliselfeld L.H. Lysosomal glycogen storage disease with normal acid maltase. Neurology 31 (1981) 51-57
50. Andrejewski N., Punnonen E.L., Guhde G., Tanaka Y., Lullmann-Rauch R., Hartmann D., von Figura K., and Saftig P. Normal lysosomal morphology and function in LAMP-1-deficient mice. J. Biol. Chem. 274 (1999) 12692-12701
51. Tanaka Y., Guhde G., Suter A., Eskelinen E.L., Hartmann D., Lullmann-Rauch R., Janssen P.M., Blanz J., von Figura K., and Saftig P. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406 (2000) 902-906
52. Stypmann J., Janssen P.M., Prestle J., Engelen M.A., Kogler H., Lullmann-Rauch R., Eckardt L., von Figura K., Landgrebe J., Mleczko A., and Saftig P. LAMP-2 deficient mice show depressed cardiac contractile function without significant changes in calcium handling. Basic Res. Cardiol. 101 (2006) 281-291
53. Huynh K.K., Eskelinen E.L., Scott C.C., Malevanets A., Saftig P., and Grinstein S. LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J. 26 (2007) 313-324
54. Jorgensen E.M., and Mango S.E. The art and design of genetic screens: Caenorhabditis elegans. Nat. Rev., Genet. 3 (2002) 356-369
55. Oh J., Ho L., Ala-Mello S., Amato D., Armstrong L., Bellucci S., Carakushansky G., Ellis J.P., Fong C.T., Green J.S., Heon E., Legius E., Levin A.V., Nieuwenhuis H.K., Pinckers A., Tamura N., Whiteford M.L., Yamasaki H., and Spritz R.A. Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am. J. Hum. Genet. 62 (1998) 593-598
56. Morgan N.V., Pasha S., Johnson C.A., Ainsworth J.R., Eady R.A., Dawood B., McKeown C., Trembath R.C., Wilde J., Watson S.P., and Maher E.R. A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8). Am. J. Hum. Genet. 78 (2006) 160-166
57. Di Pietro S.M., and Dell'Angelica E.C. The cell biology of Hermansky-Pudlak syndrome: recent advances. Traffic 6 (2005) 525-533
58. Nazarian R., Falcon-Perez J.M., and Dell'Angelica E.C. Biogenesis of lysosome-related organelles complex 3 (BLOC-3): a complex containing the Hermansky-Pudlak syndrome (HPS) proteins HPS1 and HPS4. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8770-8775
59. Martina J.A., Moriyama K., and Bonifacino J.S. BLOC-3, a protein complex containing the Hermansky-Pudlak syndrome gene products HPS1 and HPS4. J. Biol. Chem. 278 (2003) 29376-29384
60. Dell'Angelica E.C., Shotelersuk V., Aguilar R.C., Gahl W.A., and Bonifacino J.S. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the β3A subunit of the AP-3 adaptor. Mol. Cell 3 (1999) 11-21
61. Peden A.A., Oorschot V., Hesser B.A., Austin C.D., Scheller R.H., and Klumperman J. Localization of the AP-3 adaptor complex defines a novel endosomal exit site for lysosomal membrane proteins. J. Cell Biol. 164 (2004) 1065-1076
62. Fontana S., Parolini S., Vermi W., Booth S., Gallo F., Donini M., Benassi M., Gentili F., Ferrari D., Notarangelo L.D., Cavadini P., Marcenaro E., Dusi S., Cassatella M., Facchetti F., Griffiths G.M., Moretta A., Notarangelo L.D., and Badolato R. Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 107 (2006) 4857-4864
63. Shim J., and Lee J. The AP-3 clathrin-associated complex is essential for embryonic and larval development in Caenorhabditis elegans. Mol. Cell 19 (2005) 452-457
64. Siintola E., Partanen S., Stromme P., Haapanen A., Haltia M., Maehlen J., Lehesjoki A.E., and Tyynela J. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129 (2006) 1438-1445
65. Vesa J., Hellsten E., Verkruyse L.A., Camp L.A., Rapola J., Santavuori P., Hofmann S.L., and Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376 (1995) 584-587
66. IBDC. Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium. Cell 82 (1995) 949-957
67. Mole S.E., Williams R.E., and Goebel H.H. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6 (2005) 107-126
68. Tyynela J., Sohar I., Sleat D.E., Gin R.M., Donnelly R.J., Baumann M., Haltia M., and Lobel P. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J. 19 (2000) 2786-2792
69. Yanagawa M., Tsukuba T., Nishioku T., Okamoto Y., Okamoto K., Takii R., Terada Y., Nakayama K.I., Kadowaki T., and Yamamoto K. Cathepsin E deficiency induces a novel form of lysosomal storage disorder showing the accumulation of lysosomal membrane sialoglycoproteins and the elevation of lysosomal pH in macrophages. J. Biol. Chem. 282 (2007) 1851-1862
70. Syntichaki P., Xu K., Driscoll M., and Tavernarakis N. Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419 (2002) 939-944
71. Kim S.J., Zhang Z., Hitomi E., Lee Y.C., and Mukherjee A.B. Endoplasmic reticulum stress-induced caspase-4 activation mediates apoptosis and neurodegeneration in INCL. Hum. Mol. Genet. 15 (2006) 1826-1834
72. Lehtovirta M., Kyttälä A., Eskelinen E.L., Hess M., Heinonen O., and Jalanko A. Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles: implications for infantile neuronal ceroid lipofuscinosis (INCL). Hum. Mol. Genet. 10 (2001) 69-75
73. Porter M.Y., Turmaine M., and Mole S.E. Identification and characterization of Caenorhabditis elegans palmitoyl protein thioesterase1. J. Neurosci. Res. 79 (2005) 836-848
74. De Voer G., van der Bent P., Rodrigues A.J., van Ommen G.J., Peters D.J., and Taschner P.E. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype. J. Inherit. Metab. Dis. 28 (2005) 1065-1080
75. Teitelbaum S.L., Abu-Amer Y., and Ross F.P. Molecular mechanisms of bone resorption. J. Cell. Biochem. 59 (1995) 1-10
76. Monroy M.A., Ross F.P., Teitelbaum S.L., and Sands M.S. Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease. Bone 30 (2002) 352-359
77. Nicot A.S., Fares H., Payrastre B., Chisholm A.D., Labouesse M., and Laporte J. The phosphoinositide kinase PIKfyve/Fab1p regulates terminal lysosome maturation in Caenorhabditis elegans. Mol. Biol. Cell 17 (2006) 3062-3074
78. Kasper D., Planells-Cases R., Fuhrmann J.C., Scheel O., Zeitz O., Ruether K., Schmitt A., Poët M., Steinfeld R., Schweizer M., Kornak U., and Jentsch T.J. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 24 (2005) 1079-1091
79. Lange P.F., Wartosch L., Jentsch T.J., and Fuhrmann J.C. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440 (2006) 220-223
80. Fisher C.E., and Howie S.E. The role of megalin (LRP-2/Gp330) during development. Dev. Biol. 296 (2006) 279-297
81. Yochem J., Tuck S., Greenwald I., and Han M. A gp330/megalin-related protein is required in the major epidermis of Caenorhabditis elegans for completion of molting. Development 126 (1999) 597-606
82. Kramer J.M. Extracellular matrix. In: Riddle D.L., Blumenthal T., Meyer B.J., and Priess J.R. (Eds). C. elegans II (1997), Cold Spring Harbor Laboratory Press, New York 471-500
83. Roudier N., Lefebvre C., and Legouis R. CeVPS-27 is an endosomal protein required for the molting and the endocytic trafficking of the low-density lipoprotein receptor-related protein 1 in Caenorhabditis elegans. Traffic 6 (2005) 695-705
84. Lennon-Dumenil A.M., Bakker A.H., Maehr R., Fiebiger E., Overkleeft H.S., Rosemblatt M., Ploegh H.L., and Lagaudriere-Gesbert C. Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J. Exp. Med. 196 (2002) 529-540
85. 2-integrin-dependent adhesion of differentiated U-937 cells. Exp. Cell Res. 312 (2006) 2515-2527
86. Hashmi S., Zhang J., Oksov Y., and Lustigman S. The Caenorhabditis elegans cathepsin Z-like cysteine protease, Ce-CPZ-1, has a multifunctional role during the worms' development. J. Biol. Chem. 279 (2004) 6035-6045
87. Schriever A.M., Friedrich T., Pusch M., and Jentsch T.J. CLC chloride channels in Caenorhabditis elegans. J. Biol. Chem. 274 (1999) 34238-34244
88. Stobrawa S.M., Breiderhoff T., Takamori S., Engel D., Schweizer M., Zdebik A.A., Bosl M.R., Ruether K., Jahn H., Draguhn A., Jahn R., and Jentsch T.J. Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron 29 (2001) 185-196
89. Starcevic M., and Dell'Angelica E.C. Identification of snapin and three novel proteins (BLOS1, BLOS2, and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1). J. Biol. Chem. 279 (2004) 28393-28401
90. Beigneux A., Withycombe S.K., Digits J.A., Tschantz W.R., Weinbaum C.A., Griffey S.M., Bergo M., Casey P.J., and Young S.G. Prenylcysteine lyase deficiency in mice results in the accumulation of farnesylcysteine and geranylgeranylcysteine in brain and liver. J. Biol. Chem. 277 (2002) 38358-38363
91. Schroeder L.D., Kremer S., Kramer M.J., Currie E., Kwan E., Watts J.L., Lawrenson A.L., and Hermann G.J. Function of the Caenorhabditis elegans ABC transporter PGP-2 in the biogenesis of a lysosome-related fat storage organelle. Mol. Biol. Cell 18 (2007) 995-1008
92. Hujova J., Sikora J., Dobrovolny R., Poupetova H., Ledvinova J., Kostrouchova M., and Hrebicek M. Characterization of gana-1, a Caenorhabditis elegans gene encoding a single ortholog of vertebrate α-galactosidase and α-N-acetylgalactosaminidase. BMC Cell Biol. 6 (2005) 5
93. Bargmann C.I. High-throughput reverse genetics: RNAi screens in Caenorhabditis elegans. Genome Biol. 2 (2001) REVIEWS1005